BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 7741129)

  • 21. Fluctuation of thrombin-antithrombin III complex in patients with acute myocardial infarction: influence of low-dose heparin administration.
    Psuja P; Lewandowski K; Turowiecka Z; Zozulińska M; Tokarz A; Zawilska K
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1990; 117(2):229-36. PubMed ID: 1697824
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interrelationship between coagulant activity and tissue-type plasminogen activator (t-PA) system in acute ischaemic heart disease. Possible role of the endothelium.
    Munkvad S; Jespersen J; Gram J; Kluft C
    J Intern Med; 1990 Oct; 228(4):361-6. PubMed ID: 1702458
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Studies of blood coagulation-fibrinolysis regarding kallikrein-kinin system in severe preeclampsia.
    Mutoh S; Kobayashi M; Hirata J; Itoh N; Maki M; Komatsu Y; Yoshida A; Sasa H; Kuroda K; Kikuchi Y
    Agents Actions Suppl; 1992; 38 ( Pt 2)():342-9. PubMed ID: 1462840
    [TBL] [Abstract][Full Text] [Related]  

  • 24. D-dimer increase after percutaneous transluminal angioplasty and clinical recurrence after primary revascularization in acute myocardial infarction? A pilot study.
    Prisco D; Antonucci E; Fedi S; Margheri M; Giglioli C; Comeglio M; Lombardi A; Chioccioli M; Abbate R; Gensini GF
    Clin Exp Med; 2001 Dec; 1(4):219-24. PubMed ID: 11918281
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical experience with primary percutaneous transluminal coronary angioplasty compared with alteplase (recombinant tissue-type plasminogen activator) in patients with acute myocardial infarction: a report from the Second National Registry of Myocardial Infarction (NRMI-2).
    Tiefenbrunn AJ; Chandra NC; French WJ; Gore JM; Rogers WJ
    J Am Coll Cardiol; 1998 May; 31(6):1240-5. PubMed ID: 9581714
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impaired fibrinolysis early after percutaneous transluminal coronary angioplasty is associated with restenosis.
    Sakata K; Miura F; Sugino H; Shinobe M; Shirotani M; Yoshida H; Mori N; Hoshino T; Takada A
    Am Heart J; 1996 Jan; 131(1):1-6. PubMed ID: 8553994
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of acute myocardial infarction location on in-hospital and late outcome after primary percutaneous transluminal coronary angioplasty versus tissue plasminogen activator therapy.
    Stone GW; Grines CL; Browne KF; Marco J; Rothbaum D; O'Keefe J; Hartzler GO; Overlie P; Donohue B; Chelliah N; Vlietstra R; Puchrowicz-Ochocki S; O'Neill WW
    Am J Cardiol; 1996 Jul; 78(1):19-25. PubMed ID: 8712112
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Studies on blood coagulation-fibrinolysis system regarding kallikrein-kinin system in the utero-placental circulation during normal pregnancy, labor and puerperium.
    Mutoh S; Kobayashi M; Hirata J; Itoh N; Maki M; Komatsu Y; Yoshida A; Sasa H; Kuroda K; Kikuchi Y
    Agents Actions Suppl; 1992; 38 ( Pt 2)():320-9. PubMed ID: 1462839
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Augmented platelet aggregation as predictor of reocclusion after thrombolysis in acute myocardial infarction.
    Nordt TK; Moser M; Kohler B; Ruef J; Peter K; Kübler W; Bode C
    Thromb Haemost; 1998 Dec; 80(6):881-6. PubMed ID: 9869154
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plasma lipoprotein (a) levels and fibrinolytic activity in acute myocardial infarction.
    Honda Y; Oshima S; Ogawa H; Sakamoto T; Miyao Y; Sakata S; Hirashima O; Moriyama Y; Yasue H
    Jpn Circ J; 1994 Dec; 58(12):869-76. PubMed ID: 7699733
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serial changes in plasma concentration of plasminogen activator inhibitor-1 before and serially after thrombolytic therapy for acute myocardial infarction.
    Goto S; Kawai Y; Handa S; Abe S; Takahashi E; Watanabe K; Hori S; Ikeda Y
    Cardiology; 1993; 82(4):280-5. PubMed ID: 8402755
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serial changes in coagulant activities after thrombolytic therapy for acute myocardial infarction.
    Goto S; Kawai Y; Abe S; Takahashi E; Handa S; Ogawa S; Watanabe K; Hori S; Ikeda Y
    Angiology; 1994 Apr; 45(4):273-81. PubMed ID: 8161005
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction. The Primary Angioplasty in Myocardial Infarction Study Group.
    Grines CL; Browne KF; Marco J; Rothbaum D; Stone GW; O'Keefe J; Overlie P; Donohue B; Chelliah N; Timmis GC
    N Engl J Med; 1993 Mar; 328(10):673-9. PubMed ID: 8433725
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased activated protein C-protein C inhibitor complex levels in patients with pulmonary embolism.
    Minamikawa K; Wada H; Wakita Y; Ohiwa M; Tanigawa M; Deguchi K; Hiraoka N; Huzioka H; Nishioka J; Hayashi T
    Thromb Haemost; 1994 Feb; 71(2):192-4. PubMed ID: 7514816
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relationship between serum lipoprotein(a) level and thrombin generation to the circadian variation in onset of acute myocardial infarction.
    Fujino T; Katou J; Fujita M; Ohta T; Harada T; Hasebe N; Kikuchi K
    Atherosclerosis; 2001 Mar; 155(1):171-8. PubMed ID: 11223439
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Alterations in the fibrinolytic system components during acute myocardial infarction.
    Ioannidou-Papayannaki E; Lefkos N; Boudonas G; Efthimiadis A; Psirropoulos D; Vogas V; Papadopoulos I; Klonizakis I
    Acta Cardiol; 2000 Aug; 55(4):247-53. PubMed ID: 11041123
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Imbalance of plasminogen activator inhibitor type-1 (PAI-1) and tissue plasminogen activator (t-PA) activity in patients with Noonan syndrome.
    Mehta P; Parker RI
    J Pediatr Hematol Oncol; 2010 Oct; 32(7):532-6. PubMed ID: 20686427
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plasma soluble P-selectin in acute myocardial infarction: effects of coronary recanalization therapy.
    Tomoda H; Aoki N
    Angiology; 1998 Oct; 49(10):807-13. PubMed ID: 9783645
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased levels of vascular endothelial cell markers in thrombotic thrombocytopenic purpura.
    Wada H; Kaneko T; Ohiwa M; Tanigawa M; Hayashi T; Tamaki S; Minami N; Deguchi K; Suzuki K; Nakano T
    Am J Hematol; 1993 Oct; 44(2):101-5. PubMed ID: 8266913
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Effect of tongguan capsule on coagulant and fibrinolysis system in patients with coronary heart disease after percutaneous coronary intervention].
    Zhang XW; Zhang MZ
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2004 Dec; 24(12):1065-8. PubMed ID: 15658645
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.